Viewing Study NCT06141460


Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2026-04-13 @ 6:03 PM
Study NCT ID: NCT06141460
Status: RECRUITING
Last Update Posted: 2024-11-14
First Post: 2023-11-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of RRG001 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)
Sponsor: Shanghai Refreshgene Technology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module